These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8531214)

  • 1. Urokinase plasminogen activator activity is increased in the myocardium during coronary artery occlusion.
    Knoepfler PS; Bloor CM; Carroll SM
    J Mol Cell Cardiol; 1995 Jun; 27(6):1317-24. PubMed ID: 8531214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in the canine model of coronary occlusion.
    Tyagi SC; Kumar S; Cassatt S; Parker JL
    Can J Physiol Pharmacol; 1996 Aug; 74(8):983-95. PubMed ID: 8960389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation and role of urokinase plasminogen activator in vascular remodelling.
    Tkachuk V; Stepanova V; Little PJ; Bobik A
    Clin Exp Pharmacol Physiol; 1996 Sep; 23(9):759-65. PubMed ID: 8911711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.
    Blasi F; Vassalli JD; Danø K
    J Cell Biol; 1987 Apr; 104(4):801-4. PubMed ID: 3031083
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
    J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines.
    Georg B; Helseth E; Lund LR; Skandsen T; Riccio A; Danø K; Unsgaard G; Andreasen PA
    Mol Cell Endocrinol; 1989 Jan; 61(1):87-96. PubMed ID: 2501120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.
    Quax PH; van Leeuwen RT; Verspaget HW; Verheijen JH
    Cancer Res; 1990 Mar; 50(5):1488-94. PubMed ID: 2105839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
    Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
    Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
    Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
    Wells JM; Strickland S
    J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the reactivities of human urokinase and the porcine tissue plasminogen activator.
    Thorsen S; Astrup T
    Haemostasis; 1976; 5(5):295-305. PubMed ID: 14058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes.
    Braungart E; Magdolen V; Degitz K
    J Invest Dermatol; 2001 May; 116(5):778-84. PubMed ID: 11348470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of acupoint-embedment of medicated-thread and acupoint-injection on expression of cortical urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in rats with cerebral ischemia-reperfusion injury].
    Kong LH; Ye YW; Zhou H; Zhou HJ; Du YJ; Cui CX
    Zhen Ci Yan Jiu; 2010 Dec; 35(6):409-14. PubMed ID: 21375013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target.
    McGuire PG; Jones TR; Talarico N; Warren E; Das A
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2736-42. PubMed ID: 12766081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer.
    Duggan C; Maguire T; McDermott E; O'Higgins N; Fennelly JJ; Duffy MJ
    Int J Cancer; 1995 May; 61(5):597-600. PubMed ID: 7768629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasis.
    Flameng W; Vanhaecke J; Stump DC; Van de Werf F; Holmes W; Guenzler WA; Flohe L; Collen D
    J Am Coll Cardiol; 1986 Jul; 8(1):118-24. PubMed ID: 3086416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure.
    Kauhanen P; Sirén V; Carpén O; Vaheri A; Lepäntalo M; Lassila R
    Circulation; 1997 Sep; 96(6):1783-9. PubMed ID: 9323062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.
    Wilson MJ; Sinha AA
    Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas.
    Protiva P; Sordat I; Chaubert P; Saraga E; Trân-Thang C; Sordat B; Blum AL; Dorta G
    Br J Cancer; 1998; 77(2):297-304. PubMed ID: 9461001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growth factor module of urokinase is the binding sequence for its receptor.
    Appella E; Blasi F
    Ann N Y Acad Sci; 1987; 511():192-5. PubMed ID: 2830824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.